Until now, patients with severe aortic stenosis had to give up much of what makes life enjoyable. But a trailblazing new procedure at the Maimonides Heart & Vascular Center means they won’t have to give up hope.
Maimonides was among the nation’s first hospitals to offer TAVR, the newest breakthrough for those considered too high-risk for traditional heart valve replacement.
“Only a handful of Heart Centers in the nation are able to provide this option for heart valve patients,” said Dr. Jacob Shani, Chair of Cardiology and co-leader of the TAVR Program at the Maimonides Heart & Vascular Center. “Our team of experts is unrivaled in exploring and developing the best therapies for cardiac problems.”
A transcatheter aortic valve replacement (TAVR) is an innovative approach to the treatment of severe aortic stenosis (narrowing of the aortic valve opening). Instead of standard open-heart surgery, a balloon catheter is placed in the femoral artery and guided into the heart. A compressed heart valve is then placed in the catheter and positioned directly inside the diseased aortic valve. Once in position, the balloon is inflated to secure the valve in place.
“TAVR is minimally invasive, with all the benefits that implies,” said Dr. Greg Ribakove, Chief of Cardiothoracic Surgery and co-leader of the TAVR Program at Maimonides. “This is clearly the best option for certain patients who cannot undergo open-heart surgery.”
The patients who underwent the procedure at Maimonides are ecstatic over the results.
“I had lost hope of ever feeling better,” said Grace Young, who had been told at other hospitals that she had no options. Now, a year after her TAVR procedure, she continues to thrive. “I feel like a whole new chapter of my life began at the age of 78! Everyone with this valve problem should speak to the folks at Maimonides and get their lives back.”
In clinical trials, TAVR has been shown to significantly improve survival compared to non-surgical therapy. It also significantly improves symptoms and quality-of-life, and reduces repeat hospitalizations compared to medical therapy. The TAVR approach is approved by the FDA for patients who have severe, symptomatic aortic stenosis and who are not eligible for open-heart surgery.
The Maimonides Heart & Vascular Center has a stellar reputation for excellence that spans over 100 years. Known as a prestigious Heart Hospital since the middle of the 20th Century, Maimonides is one of the most comprehensive cardiac centers in the nation, offering invasive and noninvasive, medical and surgical, adult and pediatric care.
The specialists at the Maimonides Heart & Vascular Center partner with referring doctors, patients and their families in exploring the most appropriate treatments for each case. Few hospitals in the nation rival its success in the treatment of cardiac disease. In fact, according to the latest report from the federal government, Maimonides is among only 25 hospitals in the US to achieve outstanding patient outcomes for heart attack, heart failure and pneumonia.
To learn more about TAVR for yourself or a loved one, call 718-283-8284 or visit http://maimo.md/K79sNJ.